[{"AccountsPayableCurrent_0_Q3_USD":5868000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":13171000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":109000.0,"OtherAssetsNoncurrent_0_Q3_USD":2928000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q3_USD":0.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_3_Q3_USD":0.0,"OtherLiabilitiesCurrent_0_Q3_USD":247000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1034000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-119000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_3_Q3_USD":259000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":493000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockSharesAuthorized_0_Q3_shares":25000000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockValue_0_Q3_USD":0.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":11904000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7649000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":2237000.0,"OperatingExpenses_3_Q3_USD":120859000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":2080000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear_0_Q3_USD":0.0,"LongTermDebtNoncurrent_0_Q3_USD":5200000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":34851000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-493000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-97588000.0,"NetIncomeLoss_1_Q3_USD":-45471000.0,"NetIncomeLoss_3_Q3_USD":-121077000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-45471000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-121077000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":-45471000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-121077000.0,"NonoperatingIncomeExpense_1_Q3_USD":-83000.0,"NonoperatingIncomeExpense_3_Q3_USD":-250000.0,"OperatingExpenses_1_Q3_USD":45399000.0,"OperatingLeaseLiability_0_Q3_USD":14141000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_3_Q3_USD":417000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_3_Q3_USD":0.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":1545000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q3_shares":3731070.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q3_USD":6.76,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_3_Q3_shares":524228.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":2957970.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":12.37,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":8215549.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":11.31,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":4.7,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_3_Q3_USD":11.33,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":17.73,"StockholdersEquity_0_Q3_USD":155549000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":331141.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":579000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":71753004.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":70129236.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_3_Q3_pure":0.008,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q3_pure":0.01,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3_Q3_pure":0.83,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q3_pure":0.82,"ProfitLoss_3_Q3_USD":-121077000.0,"PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_0_Q3_USD":2131000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":35275000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":94645000.0,"RestrictedCashNoncurrent_0_Q3_USD":478000.0,"RetainageDeposit_0_Q3_USD":2450000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-401496000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":1907000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":11000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_1_Q3_USD":395000.0,"RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_3_Q3_USD":609000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":3783000.0,"SecurityDeposit_0_Q3_USD":478000.0,"ShareBasedCompensation_3_Q3_USD":13549000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q3_pure":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_3_Q3_pure":0.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":32000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":1213000.0,"LongTermDebtCurrent_0_Q3_USD":0.0,"LongTermDebt_0_Q3_USD":5077000.0,"CommonStockSharesAuthorized_0_Q3_shares":175000000.0,"CommonStockSharesIssued_0_Q3_shares":71865399.0,"CommonStockSharesOutstanding_0_Q3_shares":71865399.0,"CommonStockValue_0_Q3_USD":7000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-45471000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-121077000.0,"ContractWithCustomerAssetNet_0_Q3_USD":0.0,"ContractWithCustomerLiability_0_Q3_USD":3955000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":3955000.0,"ContractWithCustomerLiabilityRevenueRecognized_1_Q3_USD":11000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":32000.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_1_Q3_USD":0.0,"ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod_3_Q3_USD":0.0,"DebtInstrumentCarryingAmount_0_Q3_USD":5200000.0,"DebtInstrumentUnamortizedPremium_0_Q3_USD":74000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":9055489.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_0_Q3_shares":39474.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":0.0,"AccruedLiabilitiesCurrent_0_Q3_USD":31715000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":1449000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":557038000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q3_USD":0.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4928000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4928000.0,"DeferredFinanceCostsNet_0_Q3_USD":197000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":13549000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":9055489.0,"Assets_0_Q3_USD":217586000.0,"AssetsCurrent_0_Q3_USD":199356000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":46000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":191707000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":192185000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-63230000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":9055489.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":71753004.0,"DepreciationDepletionAndAmortization_3_Q3_USD":644000.0,"EarningsPerShareBasic_3_Q3_USD":-1.73,"InterestExpense_3_Q3_USD":286000.0,"InterestExpenseDebt_1_Q3_USD":90000.0,"InterestExpenseDebt_3_Q3_USD":267000.0,"InterestPaidNet_3_Q3_USD":187000.0,"InvestmentIncomeInterest_1_Q3_USD":15000.0,"InvestmentIncomeInterest_3_Q3_USD":36000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":18146000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":3795000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":4027000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":3909000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":958000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":4005000.0,"Liabilities_0_Q3_USD":62037000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":217586000.0,"LiabilitiesCurrent_0_Q3_USD":44022000.0,"InterestExpense_1_Q3_USD":98000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":4104000.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":617000.0,"IncreaseDecreaseInOperatingLeaseLiability_3_Q3_USD":-1236000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.63,"EarningsPerShareDiluted_3_Q3_USD":-1.73,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":6285000.0,"FinanceLeaseLiability_0_Q3_USD":755000.0,"FinanceLeaseLiabilityPaymentsDue_0_Q3_USD":804000.0,"FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":269000.0,"FinanceLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":141000.0,"EarningsPerShareBasic_1_Q3_USD":-0.63,"FinanceLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":262000.0,"FinanceLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":49000.0,"FinanceLeasePrincipalPayments_3_Q3_USD":139000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":10124000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":26214000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-2429000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":16047000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-32000.0,"FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":76000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":70129236.0,"Ticker":"MRSN","CIK":"1442836","name":"MERSANA THERAPEUTICS, INC.","OfficialName":"Mersana Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"345233797.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]